Company: IMNN
Filing Date: 2025-06-13
Form Type: 424B3
Source: 0001641172-25-015119
Chunk: 28

Company: Imunon, Inc.
Filing Date: 2025-06-13
Form: 424B3
Chunk 28
---
 Report on Form 10-K of the Company for 
 the fiscal year ended December 31, 2024.                                                                                           |

| 19 |

In addition, all documents subsequently filed by us pursuant to Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act, prior to the termination of the offering (excluding any information furnished rather than filed), shall be deemed to be incorporated by reference into this prospectus.

Any statement contained in this prospectus or in a document incorporated or deemed to be incorporated by reference into this prospectus will be deemed to be modified or superseded for purposes hereof to the extent that a statement contained in this prospectus or any other subsequently filed document that is deemed to be incorporated by reference into this prospectus modifies or supersedes the statement. Any statement so modified or superseded will not be deemed, except as so modified or superseded, to constitute a part of this prospectus.

You may request a free copy of any of the documents incorporated by reference in this prospectus (other than exhibits, unless they are specifically incorporated by reference in the documents) by writing or telephoning us at the following address:

<div align='center'>Imunon, Inc.

997 Lenox Drive, Suite 100

Lawrenceville, NJ 08648

(609) 896-9100</div>

Exhibits to the filings will not be sent, however, unless those exhibits have specifically been incorporated by reference in this prospectus.

The documents incorporated by reference may be accessed at our website: http://www.imunon.com.

| 20 |

<div align='center'>IMUNON, INC.

UP TO 22,027,780 SHARES OF COMMON STOCK

PROSPECTUS

June 13 , 2025</div>